32-week Weight Loss Study for People With Obesity Without Diabetes

Written By Patrick Smith

Are you living with obesity and do not have diabetes?  

If so, you may be eligible to participate in a clinical research study assessing an investigational GLP-1 medicine called NNC0662-0419.

ABOUT THE STUDY

This is a Phase 2 study evaluating how NNC0662-0419 affects body weight.

WHO MAY QUALIFY? 

You may be eligible to participate if you meet all the following: 

  • Age 18 years or older

  • Body mass index (BMI) of 30 or higher (classified as obesity)

  • Do not have diabetes

  • Have not used any GLP-1-based medication — including pills or injections (such as Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Trulicity, or Foundayo) within the past 3 months

  • Have not used metformin within the past 3 months

  • Have never had surgery or a weight loss device for treatment of obesity

INTERESTED IN LEARNING MORE? 

Click below to complete a short questionnaire to see if you may be eligible.
(JotForm link)

Study Sponsor: Novo Nordisk A/S

ClinicalTrials.gov ID: NCT07639021 https://clinicaltrials.gov/study/NCT07639021

Patrick Smith
Previous

3-year Prevention Study for People With Overweight and Prediabetes, Prehypertension, and/or Predyslipidemia
Next

69-week Weight Loss Study for People With Overweight or Obesity Without Diabetes